Status:
COMPLETED
The Role of Periodontal Diseases and Stimulation of Saliva Secretion in the Acute Phase of Ischemic Stroke
Lead Sponsor:
Pomeranian Medical University Szczecin
Conditions:
Periodontal Diseases
Saliva Altered
Eligibility:
All Genders
48-80 years
Phase:
NA
Brief Summary
Methods: 100 consecutive patients with their first ever ischemic stroke were enrolled in the study. 56 randomly selected patients were subjected to stimulation of salivation, the remaining patients we...
Detailed Description
The course of an ischemic stroke varies by many factors. The influence of periodontal diseases and the stimulation of salivation on the course and difficulty of stroke remains unresolved. Methods: 10...
Eligibility Criteria
Inclusion
- men and women,
- at the age of 48-80,
- first-ever stroke,
- with symptoms from the anterior cerebral vascularity (basin of the internal carotid artery),
- with a significant neurological deficit (minimum 3 points according to the NIH scale)
- capable of giving informed consent;
Exclusion
- aphasia, disturbance of consciousness, mental disorders - making it impossible to express informed consent
- surgery of the salivary glands - disrupting the secretion of saliva
- diseases of the salivary glands that disrupt the secretion of saliva (diabetes, Sjögren's syndrome, state after radiotherapy in the area of the salivary glands)
Key Trial Info
Start Date :
January 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 26 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05394090
Start Date
January 24 2020
End Date
April 26 2021
Last Update
May 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Departmen of Neurology
Szczecin, Unii Lubelskiej, Poland, 71-228